Autonomix Medical, Inc. is projected to decline to $3.23 by 2027, a -11% move from its current price of $3.65. AMIX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.35 | $3.65 | $3.98 | 0.00% |
| Aug 6 | $3.23 | $3.65 | $4.12 | 0.00% |
| Aug 7 | $3.14 | $3.65 | $4.24 | -0.01% |
| Aug 8 | $3.07 | $3.65 | $4.34 | -0.01% |
| Aug 9 | $3.01 | $3.65 | $4.43 | -0.01% |
| Aug 10 | $2.95 | $3.65 | $4.51 | -0.01% |
| Aug 11 | $2.90 | $3.65 | $4.59 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.90 | $3.65 | $4.59 | -0.01% |
| Week 2 | $2.64 | $3.65 | $5.04 | -0.03% |
| Week 3 | $2.46 | $3.65 | $5.42 | -0.04% |
| Week 4 | $2.31 | $3.65 | $5.76 | -0.05% |
| Week 5 | $2.19 | $3.65 | $6.08 | -0.07% |
| Week 6 | $2.08 | $3.65 | $6.38 | -0.08% |
| Week 7 | $1.99 | $3.65 | $6.67 | -0.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Autonomix Medical, Inc. is a development stage medical device company focusing on sensing and treating disorders of nervous system.
Its technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.
Autonomix Medical was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Autonomix Medical, Inc. trades in the Healthcare sector under the symbol AMIX. The current price is $3.59 and the market capitalization is $1.95M, with a market-cap ranking of 5153.
The near-term outlook shows a neutral to bearish setup, while the longer-range forecasts portray a path of gradual appreciation later in the horizon. The 2026 forecast lists an average price of $3.59 with a 0% ROI and Neutral sentiment, suggesting a flat start to the projection period.
Looking further out, the forecast suite shows a potential rise in several later years, including a 2030 average of $3.74 and a 2050 average of $11.37, with a maximum forecast of $26.16 and a 216.8% ROI by 2050, indicating meaningful upside under certain conditions.
A major floor 92.2% below — a decisive break under it would weaken the trend.
The nearest floor, 24.7% below — buyers have tended to step in here.
The nearest ceiling, 118.6% above — a clean break opens room to run.
A major ceiling 193.2% above — clearing it would confirm fresh momentum.
Key AMIX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMIX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.43 | Buy | $3.57 | Buy |
| MA 10 | $3.61 | Buy | $3.79 | Sell |
| MA 20 | $4.72 | Sell | $4.06 | Sell |
| MA 50 | $3.10 | Buy | $3.38 | Buy |
| MA 100 | $1.74 | Buy | $2.41 | Buy |
| MA 200 | $1.21 | Buy | $2.24 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.40 | Neutral |
| Stoch RSI (14) | 44.95 | Neutral |
| CCI (20) | -74.84 | Neutral |
| Williams %R (14) | -71.72 | Info |
| MACD (12,26,9) | -0.27 | Sell |
| ROC (12) | -32.94 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 28.28 | Neutral |
| TRIX (15) | 0.70 | Buy |
| Awesome (5,34) | -0.95 | Sell |
| Ultimate (7,14,28) | 42.09 | Neutral |
| Momentum (10) | -1.01 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 3.73 | Sell |
| ADX (14) | 22.55 | Sell |
| ATR (14) | 0.46 | Info |
The 30-day technical picture is Bearish.
The RSI(14) sits at 40, and the stock trades below both the 50-day and 200-day moving averages, with SMA50 at $6.64 and SMA200 at $10.92.
Support is cited at $2.75 and resistance at $8.17, while the 30-day range runs from $2.00 to $6.45, underscoring a tight, downward-leaning near-term setup amid high volatility (annualized around 200%).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.75 | $3.65 | $5.07 | 0% | Neutral | |
| $2.36 | $3.23 | $4.79 | -11% | Neutral | |
| $2.13 | $3.11 | $4.92 | -15% | Neutral | |
| $1.99 | $3.06 | $5.08 | -16% | Bearish | |
| $2.38 | $3.83 | $6.64 | +5% | Neutral | |
| $2.58 | $4.36 | $7.81 | +19% | Neutral | |
| $2.61 | $4.59 | $8.48 | +26% | Bullish | |
| $2.49 | $4.56 | $8.67 | +25% | Bullish | |
| $1.91 | $3.64 | $7.09 | 0% | Neutral | |
| $1.88 | $3.72 | $7.41 | +2% | Neutral | |
| $2.23 | $4.96 | $10.89 | +36% | Bullish | |
| $5.22 | $11.60 | $26.69 | +218% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.75 | $3.65 | $4.78 | +0.00% |
| September 2026 | $3.18 | $3.87 | $4.91 | +5.97% |
| October 2026 | $2.96 | $3.64 | $4.72 | -5.79% |
| November 2026 | $2.96 | $3.68 | $4.85 | +1.12% |
| December 2026 | $3.01 | $3.80 | $5.07 | +3.05% |
Click any year to see its month-by-month AMIX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AMIX to range from $2.75 to $5.07 through 2026. The $3.65 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AMIX price prediction for 2027 points to an average of $3.23 (low $2.36, high $4.79) — a potential decline of -11% on today's $3.65. A consolidation phase looks the most probable path here.
In 2028, AMIX is projected to trade between $2.13 and $4.92, averaging $3.11 — a potential decline of -15% from today's $3.65. That is -4% versus the projected 2027 average. Price action looks broadly range-bound.
Autonomix Medical, Inc.'s 2029 outlook centres on $3.06, within a $1.99 to $5.08 range. That is -2% versus the projected 2028 average. That marks a -16% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2030, AMIX could reach as high as $6.64, with a base case around $3.83 and support toward $2.38 — roughly +5% from $3.65. Price action looks broadly range-bound.
Expect AMIX to range from $2.58 to $7.81 through 2031. The $4.36 average target implies a +19% move from current prices. That is up +14% on the projected 2030 average. A consolidation phase looks the most probable path here.
The AMIX price prediction for 2032 points to an average of $4.59 (low $2.61, high $8.48) — a potential gain of +26% on today's $3.65. Momentum favours further upside here.
In 2033, AMIX is projected to trade between $2.49 and $8.67, averaging $4.56 — a potential gain of +25% from today's $3.65. That is -1% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Autonomix Medical, Inc.'s 2034 outlook centres on $3.64, within a $1.91 to $7.09 range. That is -20% versus the projected 2033 average. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2035, AMIX could reach as high as $7.41, with a base case around $3.72 and support toward $1.88 — roughly +2% from $3.65. A consolidation phase looks the most probable path here.
Expect AMIX to range from $2.23 to $10.89 through 2040. The $4.96 average target implies a +36% move from current prices. That is up +34% on the projected 2035 average. Momentum favours further upside here.
The AMIX price prediction for 2050 points to an average of $11.60 (low $5.22, high $26.69) — a potential gain of +218% on today's $3.65. Buyers look set to stay in control over this stretch.
Investing $1,000 in AMIX today (≈ 273.972603 AMIX) could be worth
$3,178.93
+$2,178.93 (+218%) by 2050 · US Dollar
Based on the average projected AMIX price of $11.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMIXwould be worth at today's price.
$1,000 invested in AMIX on Jul 31, 2025 (≈ 694.444417 AMIX) would be worth
$2,534.72
+$1,534.72 (+153.5%) today · 2.53× · US Dollar
Based on a AMIX entry price of $1.44 vs. today's $3.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.92 | $1,250 | +25.0% |
| 1 month ago | $6.9 | $528.99 | -47.1% |
| 3 months ago | $0.37 | $9,864.86 | +886.5% |
| 6 months ago | $0.405 | $9,012.35 | +801.2% |
| 1 year ago | $1.44 | $2,534.72 | +153.5% |
| All time (2.5y) ago | $101.4 | $36 | -96.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMIX forecast.
Our base-case forecast reaches $7.30 around 2050.
Implied market cap at $7.30: $3.96M
The multi-year forecast shows a transition from neutral to bullish sentiment in the outer years. The 2026 period is neutral, and the asset’s path turns more bullish by 2031, with 2031 at an average of $4.33 and 2032 at $4.51, continuing a growth trajectory through 2033 ($4.45) and into 2040 ($4.94 average). The 2030 forecast sits at an average of $3.74 with a 4% ROI, while the 2040 forecast registers a 37.6% ROI with an average of $4.94 and a max of $10.83.
By 2050 the forecast shows a strong upside with an average of $11.37 and a max of $26.16, delivering a 216.8% ROI and a bullish sentiment. These figures imply substantial upside potential even as near-term volatility and downside risk remain part of the path. Investors should weigh the near-term weakness against the long-run upside implied by the final-year projections.
Tap a question to reveal the answer.
The 2030 forecast shows min $2.31, avg $3.74, max $6.47, with ROI 4% and Neutral sentiment.
The near-term forecast for 2026 lists avg $3.59, ROI 0%, and Neutral sentiment, indicating a flat near-term outlook.
The 2040 forecast shows max $10.83 and avg $4.94, with ROI 37.6% and Bullish sentiment, suggesting potential upside into the decade.
For 2050, the forecast lists min $5.12, avg $11.37, max $26.16, ROI 216.8%, with a Bullish sentiment.
Current price is $3.59 and market capitalization is $1.95M.
Autonomix Medical, Inc. Community Discussion
0Share your Autonomix Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.